Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Chromogranin A Precursor Polyclonal Antibody

Goat Polyclonal Antibody
Supplier: Invitrogen™ PA518527
Description
This antibody is tested in Peptide ELISA: antibody detection limit dilution 128,000.
The protein encoded by this gene is a member of the chromogranin/secretogranin family of neuroendocrine secretory proteins. It is found in secretory vesicles of neurons and endocrine cells. This gene product is a precursor to three biologically active peptides; vasostatin, pancreastatin, and parastatin. These peptides act as autocrine or paracrine negative modulators of the neuroendocrine system. Other peptides, including chromostatin, beta-granin, WE-14 and GE-25, are also derived from the full-length protein. However, biological activities for these molecules have not been shown.
Specifications
Chromogranin A Precursor | |
Polyclonal | |
Unconjugated | |
CHGA | |
AL-11; betagranin (N-terminal fragment of chromogranin A); catestatin; CgA; CHGA; chromofungin; chromogranin A; chromogranin-A; EA-92; ER-37; ES-43; GE-25; GR-44; GV-19; LF-19; Pancreastatin; Parastatin; parathyroid secretory protein 1; p-Glu serpinin precursor; pituitary secretory protein I; Serpinin; Serpinin-RRG; SL21; SP1; SP-I; SS-18; Vasostatin; Vasostatin I; Vasostatin II; Vasostatin-1; Vasostatin-2; WA-8; WE-14 | |
Goat | |
Ammonium sulfate precipitation | |
RUO | |
1113 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Flow Cytometry, Western Blot | |
0.5 mg/mL | |
TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 | |
P10645 | |
CHGA | |
Synthetic peptide sequence (QGAKERAHQQKKH) corresponding to the internal amino acids of CHGA (aa 85-98). | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction